Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated Fertility
N/A
18 Years
37 Years
18 Years
37 Years
Open (Enrolling)
Female
Breast Cancer, Fertility
Female
Breast Cancer, Fertility
Trial Information
Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated Fertility
Inclusion Criteria:
- 18 ≤ age < 38
- breast cancer histologically proved
- under the control of an adjuvant chemotherapy or neo adjuvant chemotherapy
- verbal agreement given
Exclusion Criteria:
- age ≥ 38
- metastatic breast cancer
- non able to follow the design of the study (geographic, social or psychological
reasons)
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
change from baseline of Anti Mullerian Hormone (AMH) rate to different time points until 24 months
Outcome Description:
variation of percentages of AMH rate compared to baseline - Observe sequential chemotherapy on ovarian follicular content
Outcome Time Frame:
baseline, Day 1 of Cycle 2, Day 1 of Cycle 4, Day 1 of Cycle 6, 3 months, 6 months, 9 months, 12 months, 24 months
Safety Issue:
No
Principal Investigator
Audrey MAILLIEZ, MD
Investigator Role:
Study Chair
Investigator Affiliation:
Oscar Lambret Center
Authority:
France: French Data Protection Authority
Study ID:
Cancer et fertilité - 1104
NCT ID:
NCT01614704
Start Date:
October 2011
Completion Date:
October 2015
Related Keywords:
- Breast Cancer
- Fertility
- Breast cancer
- Fertility
- Breast Neoplasms
Name | Location |
|---|
